Cardiotoxicity and Herceptin (Cont.)

Final Thoughts on Cardiotoxicity and Herceptin

As with many monoclonal antibodies, Herceptin appears to increase the risk of congestive heart failure. However, for many people, the potential benefits of Herceptin outweigh the risks of cardiotoxicity. With careful monitoring and patient selection, these risks can be reduced.
Pages:

Previous 1   2

Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;